• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

Pharmaceutical Bundle

  • ID: 2245727
  • January 2011
  • Region: Global
  • 1679 Pages
  • TriMark Publications

The Pharmaceutical Bundle offers a 15% discount off the total transaction price for the following reports being purchased simultaneously:

- Anti-Infective Drugs Markets
- Cell Therapy Markets
- Cell-Based Assays for Drug Discovery
- Companion Biomarkers in Drug Development
- Indian Pharmaceutical Industry
- Medical Nanotechnology Markets
- Pharmacogenomics for Clinical Use and in Drug Development
- Therapeutic Monoclonal Antibodies Markets

Anti-Infective Drugs Markets

Six infectious diseases -- pneumonia, tuberculosis, diarrheal diseases, malaria, measles and HIV/AIDS -- account for half of all premature deaths worldwide, killing mostly children and young adults, according to the World Health Organization (WHO). Moreover, threatening pandemics such as swine flu (H1N1 influenza A virus) are adding significant pressure to already strained healthcare budgets of governments around the world. This report analyzes the anti-infective drugs market and highlights the existing and developing anti-infectives used to ameliorate infectious diseases' afflictions on humankind. Anti-infective drugs include: anti-viral therapeutics, antibiotics, anti-fungal READ MORE >

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown



Our Clients

Pfizer, Inc. Grünenthal GmbH GlaxoSmithKline PLC Abbott Laboratories Ltd. Roche Diagnostics Ltd. Novo Nordisk A/S